awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26779612-24051D5B-539A-4E26-8EDE-CB5C4A5D7BDD
Q26779612-24051D5B-539A-4E26-8EDE-CB5C4A5D7BDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26779612-24051D5B-539A-4E26-8EDE-CB5C4A5D7BDD
Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma
P2860
Q26779612-24051D5B-539A-4E26-8EDE-CB5C4A5D7BDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26779612-24051D5B-539A-4E26-8EDE-CB5C4A5D7BDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a918bbbc0d0e0c3f4d66b2887bb278bd6cd6b37c
P2860
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.